Bristol to close up shop in Pakistan

Bristol-Myers Squibb is poised to pull out of Pakistan, newspapers there are reporting, saying that the drugmaker has been soliciting offers for its local business from the Pakistani pharma industry. Report

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

The role of distributors like AmerisourceBergen, is to ensure patients can get access to therapies, no matter where they present.